| Title: |
Blood lactate in mild and moderate ARDS secondary to SARS COV 2 |
| Authors: |
Pagano, A; Porta, G; Bosso, G; Allegorico, E; Serra, C; Mercurio, V; Sansone, G; Orefice, S; Numis, F G |
| Contributors: |
Pagano, A; Porta, G; Bosso, G; Allegorico, E; Serra, C; Mercurio, V; Sansone, G; Orefice, S; Numis, F G |
| Publication Year: |
2023 |
| Collection: |
IRIS Università degli Studi di Napoli Federico II |
| Description: |
Background and objectives: Elevated blood lactate levels are associated with poor outcome in several critical conditions. Patients with SARS-CoV-2 rarely develop hyperlactatemia. The purpose of this study is to evaluate the trend of lactatemia in patients affected by mild/moderate SARS-Co V-2-ARDS and if it affected prognosis. Methods: We analyzed blood lactate levels in thirty-eight patients with severe SARS-CoV-2 infection admitted to COVID Care Unit of Santa Maria delle Grazie Hospital, Pozzuoli. Results: Twenty patients survived and were discharged at home and 18 patients died. Despite severe hypoxia that affected all patients enrolled, T0 lactate was within normal values. All survivors showed a significant increase in lactate concentration the day prior to clinical improvement. In not-survivors levels of lactate did not increase significantly. Conclusion: In our study, patients who survive SARS CoV-2 ARDS have a fleeting increase in lactate, which precedes clinical improvement by one day. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/wos/WOS:000964524900001; volume:66; firstpage:73; lastpage:75; numberofpages:3; journal:THE AMERICAN JOURNAL OF EMERGENCY MEDICINE; https://hdl.handle.net/11588/931683 |
| DOI: |
10.1016/j.ajem.2023.01.032 |
| Availability: |
https://hdl.handle.net/11588/931683; https://doi.org/10.1016/j.ajem.2023.01.032 |
| Rights: |
info:eu-repo/semantics/restrictedAccess ; license:Non specificato ; license uri:na |
| Accession Number: |
edsbas.85C685ED |
| Database: |
BASE |